A Randomized, Double-Blind, Placebo and Positive Controlled, Parallel Group Trial to Investigate the Effect of Multiple Doses of NOMAC-E2 on QT/QTc Interval in Healthy Women
Phase of Trial: Phase I
Latest Information Update: 25 Nov 2014
At a glance
- Drugs Estradiol/nomegestrol (Primary)
- Indications Pregnancy
- Focus Adverse reactions
- Sponsors Merck & Co; Merck Sharp & Dohme
- 29 Apr 2014 Results published in the Clinical Drug Investigation.
- 12 Oct 2012 Results presented at the 20th FIGO World Congress of Gynecology and Obstetrics.
- 28 Oct 2009 Schering-Plough added as trial sponsor as reported by ClinicalTrials.gov.